Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study

Adaptive immunity to SARS-CoV-2 and COVID-19

(2021) Alessandro Sette et al.   CELL

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond

(2021) Emily Bettini et al.   Vaccines

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

(2021) Christian Holm Hansen et al.   LANCET

A correlate of protection for SARS-CoV-2 vaccines is urgently needed

(2021) Florian Krammer   NATURE MEDICINE

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

(2021) Yinon M. Bar-On et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

(2021) Mark W. Tenforde et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months Postinfection

(2021) Zhongyan Lu et al.   JOURNAL OF INFECTIOUS DISEASES

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

(2021) Alice Cho et al.   NATURE

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

(2021) Einav G. Levin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

(2021) Hiam Chemaitelly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

(2021) Barak Mizrahi et al.   Nature Communications

Setting the criteria for SARS-CoV-2 reinfection – six possible cases

(2020) Sara Tomassini et al.   JOURNAL OF INFECTION

What reinfections mean for COVID-19

(2020) Akiko Iwasaki   LANCET INFECTIOUS DISEASES